NHLBI Catalyze grants fund platform technologies to accelerate the development of diagnostics and therapeutics for heart, lung, blood, and sleep disorders.
NHLBI Catalyze funds early research to find and validate drug therapies for heart, lung, blood, and sleep disorders, preparing them for further development.
NHLBI Catalyze program supports early-stage research to identify and characterize small molecule, biologic, and combination product therapeutic candidates for heart, lung, blood, and sleep (HLBS) disorders.
NHLBI Catalyze program supports early-stage medical device prototype optimization and translational research for heart, lung, blood, and sleep (HLBS) diseases.
NHLBI Catalyze funds early-stage medical device prototypes, disease target ID, & assay development for heart, lung, blood, & sleep disorders, aiming to prep projects for further testing.
Funds Phase I clinical trials for diagnostic/therapeutic interventions in heart, lung, blood, and sleep disorders in adults/children, allowing preclinical activities and milestone-driven support.